Details

---

Manufacturer
H. LUNDBECK A/S(DENMARK)
Registraction Number
MAL24086006AZ

Contents

Active Ingredient: Eptinezumab-jjmr, 100 mg/mL.
Formulation: A sterile, preservative-free solution for intravenous infusion.

Indications

Vyepti is used for:
Preventive treatment of migraines in adults who experience migraines at least 4 days per month.
It works by blocking the activity of calcitonin gene-related peptide (CGRP), a substance involved in migraine attacks.

Instructions

Administration:
Vyepti is administered as an intravenous (IV) infusion by a healthcare professional.
The infusion typically takes about 30 minutes and is given every 3 months.
Dosage: The recommended dose is 100 mg, but some patients may require 300 mg based on their condition.
Precautions:
Avoid use if allergic to eptinezumab or any of its ingredients.
Inform your doctor if you are pregnant, breastfeeding, or have cardiovascular conditions.
Monitor for potential allergic reactions during or after the infusion.
Storage: Store in a refrigerator (2–8°C). Do not freeze.